作为一种非药物治疗方式治疗严重抑郁症经颅磁刺激(TMS)效果明显以往的研究主要观察的终点指标是蒙哥马利抑郁评定量表(MADRS)的症状评分变化次要终点包括，诊断标准按国际公认通用的HAMD抑郁评定量表SDS抑郁自评量表和SPIEGEL睡眠量表抑郁症引起的慢性失眠...
基于186个网页-相关网页
...抑郁评定量表(Hamilton Rating Scale for Depression,HAMD)和蒙特玛莉抑郁评定量表(Montgomery-Asberg depression rating scale,MADRS) [1],并由这些量表分值的变化来判定抑郁的改变程度.
基于4个网页-相关网页
汉米尔顿抑郁评定量表 Hamilton Rating Scale for Depression
经简易抑郁评定量表 ZUNG
和汉密顿抑郁评定量表 HRSD
医院焦虑抑郁评定量表 hospital anxiety and depression scale
但与儿童抑郁评定量表 Children's Depression Rating Scale
抑郁自我评定量表 self-rating depression scale ; SDS
抑郁症自我评定量表 Zung Self-rating Depression Scale ; ZUNG-SDS
自我评定抑郁量表 Self-Rated Depression Scale
蒙哥马利抑郁量表评定 Montgomery Asberg depression rating scale ; MADRS
以汉密尔顿抑郁评定量表17项作为主要疗效评价指标。
The main efficacy measure was the change in total score of the Hamilton Depression Scale 17 item (HAMD17) from baseline to endpoint.
方法对18例抑郁症和10例正常人评定汉密尔顿抑郁评定量表(HA MD)和检测睡眠脑电图。
Methods it was estimated for Hamilton Depressive Rating Scale (HAMD) and the parameters of Sleep EEG in 18 patients with depression and 10 normal controls.
依照《儿童抑郁评定量表——修订版》得分少于或等于28分的标准，在36周，最初服用安慰剂的患者缓解率为48，这比积极治疗患者中59%的缓解率要低。
The rate of remission, defined as having a score of 28 or loweron the Children's Depression Rating Scale–Revised, atweek 36, was 48 percent in patients who received initial placebo.
应用推荐